Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Oct 16, 2014; 2(10): 596-603
Published online Oct 16, 2014. doi: 10.12998/wjcc.v2.i10.596
Published online Oct 16, 2014. doi: 10.12998/wjcc.v2.i10.596
Figure 1 Monitoring used for redo-stenotomy and aortic valve replacement.
A: Cerebral oximeter (Invos, Somanetics®); B: Bispectral index; C: 9 French Internal jugular sheath; D: Continuous cardiac output and mixed venous oximetry measured with a fiberoptic pulmonary artery catheter (Edwards Lifesciences, Irvine CA); E: 4-lumen central venous catheter.
- Citation: Weinberg L, Kearsey I, Tjoakarfa C, Matalanis G, Galvin S, Carson S, Bellomo R, McNicol L, McCall P. Haemostatic management for aortic valve replacement in a patient with advanced liver disease. World J Clin Cases 2014; 2(10): 596-603
- URL: https://www.wjgnet.com/2307-8960/full/v2/i10/596.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i10.596